Enveric Biosciences, Inc. - SIC # 8231 - LIBRARIES

Ticker Exchange SIC # Website Latest Ticker
ENVB Nasdaq 8231 www.enveric.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Enveric Biosciences, Inc.

Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003 - May 19th, 2026 6:00 am
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026 - May 15th, 2026 6:00 am
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders - May 13th, 2026 6:00 am
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model - May 5th, 2026 6:00 am
Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - Apr 28th, 2026 5:33 am
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum - Apr 21st, 2026 6:00 am
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Apr 17th, 2026 4:28 pm
Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Apr 16th, 2026 6:00 pm
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates - Mar 31st, 2026 6:00 am
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025 - Mar 27th, 2026 3:40 pm
Enveric Biosciences Announces Registration of Five Trademarks - Mar 18th, 2026 6:00 am
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent - Feb 25th, 2026 6:00 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Feb 22nd, 2026 5:43 pm
Enveric Biosciences reports EB-003 receptor engagement assay data - Feb 20th, 2026 6:09 am
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data - Feb 19th, 2026 6:00 am
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Jan 29th, 2026 6:00 am
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Jan 28th, 2026 3:00 pm
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Jan 28th, 2026 6:00 am
Enveric Biosciences announces issuance of U.S. patent - Dec 30th, 2025 6:10 am
Enveric Biosciences Announces Patent Issuance - Dec 29th, 2025 6:00 am